Lately we were granted a EU H2020-SMEINST-1-2014 project for our Proposal No: 673533 – DryEye – SME-1. The project is about our biomarker for the diagnosis of dry-eye syndrome.
European Commission invited us to participate in the H2020 Project MSCA-RISE-2016/H2020-MSCA-RISE-2016
Proposal: 734907 — 3D NEONET since January 2017 and for the next 48 months. The Project is directed by the Irish University College of Dublin.
Since 1st of January 2020, we participate to H2020 MSCA-ITN Project named ORBITAL, Proposal 813440. The Project is directed by the Irish Waterford Institute of Technology and we recruited a PhD student to prepare a Doctorate Thesis with the title Development of a novel biomarker cocktail for the diagnosis-screening of drug delivery and treatment efficacy in age-related ocular diseases
European Commission invited us to participate in the H2020 Project MSCA-RISE-2020/H2020-MSCA-RISE-2020
Proposal: 101007931— CRYSTAL3 since January 2021 for the next 48 months. The Project is directed by the Irish University College of Dublin.
NEW SERVICE PROVIDED
(Eng)
Assistance to companies that manufacture and/or market «health products» in the field of Ophthalmology, Optometry and any other ocular application.
The entry into force of the MDR (Medical Device Regulation) poses a series of challenges to pharmaceutical companies if they intend to maintain the “CE” marking on their products or if they intend to introduce new ones to the market.
Aspects such as the necessary preclinical and clinical studies, critical reviews of the literature, trend reports and safety reports, in many cases require the participation of researchers who not only have experience in this field, but also have significant clinic experience.
Aware of this, we created an alliance between the companies Vision R&D, linked to the University of Valladolid, OcuPharm Diagnostics, linked to the Complutense University of Madrid, and Carjes Soluciones, Specialized Consulting in the health sector, to assist companies in a wide variety of aspects ranging from regulatory, preclinical tests and clinical studies adapted to the product and the needs of the companies.
The vast experience of these three companies with a high clinical and investigative component completely focused on eye products makes it possible to propose and execute solutions that allow companies to comply with the regulations contained in the MDR.
(Esp)
Asistencia a empresas que fabrican y/o comercializan “productos sanitarios” del ámbito de la Oftalmología, la Optometría y cualquier aplicación ocular.
La entrada en vigor del MDR (Medical Device Regulation) plantea a las empresas una serie de retos si pretenden mantener el marcado “CE” en sus productos o si pretenden introducir nuevos en el mercado.
Aspectos como los estudios preclínicos y clínicos necesarios, los análisis críticos de la bibliografía, los informes de tendencia y los de seguridad, exigen en muchos casos, la participación de investigadores que no solo tengan experiencia en este campo, sino que tengan también una importante experiencia clínica.
Conscientes de ello, se ha establecido una alianza entre Visión R&D, ligada a la Universidad de Valladolid, OcuPharm Diagnostics, ligada a la Universidad Complutense de Madrid, y Carjes Soluciones, Consultoría Especializada en el sector de la salud, para ayudar a las empresas en una amplia variedad de aspectos que van desde la regulatoria, pruebas preclínicas y estudios clínicos adaptados al producto y a las necesidades de las compañías.
La vasta experiencia de estas tres empresas con un alto componente clínico e investigador completamente focalizado en productos oculares permite proponer y ejecutar soluciones que permitan a las empresas el cumplimiento de la normativa recogida en el MDR.
